Sola Security Launches Lumina, an Autonomous Security Deep Research Platform for Actionable Risk Intelligence Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program
Targeting initiation of dose confirmation trial by end of 2021 with data readout by end of…
OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics
SUWON, Republic of Korea, Feb. 08, 2021 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950),…
China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)
SAN JOSE, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac…
Zedge Reveals Impressive 2020 App and User Highlights
NEW YORK, NY / ACCESSWIRE / February 8, 2021 / Zedge, Inc. (NYSE AMERICAN:ZDGE), a…
Qilian International Holding Group Limited to Triple Organic Fertilizer Production Capacity by March 2021
Jiuquan, China, Feb. 08, 2021 (GLOBE NEWSWIRE) — Qilian International Holding Group Limited (Nasdaq: QLI)…
Ron Little, P.Eng Joins Board Of Directors Of Gold Resource Corporation
DENVER, CO / ACCESSWIRE / February 8, 2021 / Gold Resource Corporation (NYSE American:GORO) (the…
Monarch Mining Reports a Significant Resource Increase at Its Mckenzie Break Property
44% increase in the Indicated resource to 145,982 ounces of gold and nearly 300% increase…
Tauriga Sciences, Inc. Establishes Two Additional UPC Category Classifications for its Flagship Brand Tauri-Gum
TAUG These Additional Classifications are: Tauri-Gum™ Cases (8 Retail Boxes) & Tauri-Gum™ Shipment Crates (48…
Orion and Bayer expand development program for darolutamide in prostate cancer
ORION CORPORATION PRESS RELEASE 8 FEBRUARY 2021 at 14.00 EET Orion and Bayer expand…
NanoViricides’s Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies
SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the…
Borussia Dortmund Reports Preliminary Figures for The First Half (H1) Of The 2020/2021 Financial Year
Despite the ongoing COVID-19 pandemic and the second lockdown, Borussia Dortmund generated a net profit…
NuRAN Announces Major Network as a Service Agreement with Orange DRC
QUEBEC, QC / ACCESSWIRE / February 8, 2021 / NuRAN Wireless Inc. (“NuRAN” or the…
Banyan Drills 18 Metres of 1.11 G/T AU From Surface at New Aurex Hill Target, Aurmac Property, Yukon
VANCOUVER, BC / ACCESSWIRE / February 8, 2021 / Banyan Gold Corp. (the “Company” or…
2021 Living Donor Protection Report Card from American Kidney Fund Reveals Where Americans Live Can Affect Their Ability to be Living Organ Donors
States vary greatly in laws that make it easier for people to give the gift…
Ubique Minerals Reports Zinc Soil Anomaly Extended by Fall 2020 Work Program
This news release is not for distribution or dissemination in the Unites States of America…
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) —…
GeneSight Psychotropic Test’s Combinatorial Approach Proves Better than Single-Gene Testing at Predicting Patient Outcomes and Medication Blood Levels
New Analysis Published in Psychiatry Research SALT LAKE CITY, Feb. 08, 2021 (GLOBE NEWSWIRE) —…
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
– Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders – – CLS-AX…
Infinite Ore Reports up to 1.60% Li2O From Shallow Surface Drilling at Jackpot Lithium Project
VANCOUVER, BC / ACCESSWIRE / February 8, 2021 / Infinite Ore Corp. (the “Company”) (TSXV:ILI)(OTCQB:ARXRF)…
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society Meeting
– Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders – – CLS-AX…